AstraZeneca (AZN) At the Center of Serious Analyst Attention [Yahoo! Finance]
AstraZeneca PLC - American Depositary Shares (AZN)
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: Yahoo! Finance
AstraZeneca PLC (NASDAQ:AZN), the British pharmaceutical company best known for its COVID-19 drug, was at the center of analyst action on December 9th after a report from TD Cowen. The report saw the firm raise the healthcare company's share price target to $105 from $95 and keep a Buy rating on the stock. TD Cowen outlined that AstraZeneca PLC (NASDAQ:AZN)'s drug pipeline and presence in high-growth markets had influenced its optimism about the firm. TD Cowen's action on AstraZeneca PLC (NASDAQ:AZN) came soon after Morgan Stanley had raised the firm's share price target to $103 from $93 on December 3rd, as per The Fly. As part of its coverage, the bank pointed out that AstraZeneca PLC (NASDAQ:AZN)'s pharmaceutical market was fundamentally stable, but investors aiming for growth should target other sectors. Copyright: dolgachov / 123RF Stock Photo The two firms' optimism for the pharma company came after Bank of America had added AstraZeneca PLC (NASDAQ:AZN) to its top stocks f
Show less
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- US is best place to invest, says boss of British drugs giant [Yahoo! Finance]Yahoo! Finance
- Cellectis' Allogeneic CAR-T Potential Still Justifies A 'Buy' [Seeking Alpha]Seeking Alpha
- Why is AstraZeneca PLC (AZN) One of the Best Pharma Stocks to Invest In? [Yahoo! Finance]Yahoo! Finance
- AstraZeneca (NASDAQ:AZN) had its "buy" rating reaffirmed by analysts at HSBC Holdings plc.MarketBeat
- AstraZeneca (NASDAQ:AZN) had its "buy" rating reaffirmed by analysts at Cowen Inc.MarketBeat
AZN
Sec Filings
- 12/4/25 - Form 6-K
- 12/1/25 - Form 6-K
- 12/1/25 - Form 6-K
- AZN's page on the SEC website